Supplemental and Archived Hib
as Published in Morbidity and Mortality Weekly Report (MMWR)
Advisory Committee on Immunization Practices (ACIP)
These MMWR publications were published in addition to the official CDC recommendations and serve as updates until the recommendations are revised and republished. These MMWRs contain important changes or supplemental recommendations that may include policy notes, changes or updates to recommendations, and notices to readers.
NOTE: As a general rule, if the official recommendations are dated later than the supplemental recommendations listed below, the official recommendations override the older items listed below.
Supplemental Hib Recommendations
- September 18, 2009, Vol 58, #36
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
- June 26, 2009, Vol 58, #24
Updated Recommendations for Use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months
- December 21, 2007, Vol 56, #50
Interim Recommendations for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB® and Comvax®)
See also Hib and DTP recommendations
- None at this time; see official Hib recommendations
Content last reviewed on April 8, 2011
Content Source: National Center for Immunization and Respiratory Diseases